Corrigendum to "N-Hydroxy-(4-oxime)-cinnamide: A versatile scaffold for the synthesis of novel histone deacetilase (HDAC) inhibitors" [Bioorg. Med. Chem. Lett. 19 (2009) 2346] (DOI:10.1016/j.bmcl.2009.02.029);N-Hydroxy-(4-oxime)-cinnamide: A versatile scaffold for the synthesis of novel histone deacetilase (HDAC) inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 19, Issue 8, 2009, Pages 2346-2349

  Giannini, Giuseppe ^a   Marzi, Mauro ^a   Pezzi, Riccardo ^a   Brunetti, Tiziana ^a   Battistuzzi, Gianfranco ^a   Marzo, Maria Di ^a   Cabri, Walter ^a   Vesci, Loredana ^a   Pisano, Claudio ^a  

^a Sigma Tau SpA   (Italy)

Author keywords

Antitumor; Cinnamide; HDAC inhibitors; Hydroxamic acids

Indexed keywords

3 PHENYLSULFAMOYLCINNAMOHYDROXAMIC ACID; 4 [N (2 HYDROXYETHYL) N [2 (3 INDOLYL)ETHYL]AMINOMETHYL]CINNAMOHYDROXAMIC ACID; BELINOSTAT; HISTONE DEACETYLASE 6; HISTONE DEACETYLASE 8; HISTONE DEACETYLASE INHIBITOR; N HYDROXY (4 OXIME)CINNAMIDE; PANOBINOSTAT; PCI 24781; SB 939; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SAFETY; DRUG SELECTIVITY; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY;

EID: 63149180510     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2009.02.128     Document Type: Erratum

References (21)

1. Bolden J.E., Peart M.J., and Johnstone R.W. Nat. Rev. Drug Discov. 5 (2006) 769
2. Dokmanovic M., Clarke C., and Marks P.A. Mol. Cancer Res. 510 (2007) 981
3. Acharya M.R., Sparreboom A., Venitz J., and Figg W.D. Mol. Pharmacol. 68 (2005) 917
4. Garber K. Nat. Biotechnol. 25 (2007) 17
5. Grant S., Easley C., and Kirkpatrick P. Nat. Rev. Drug Discov. 6 (2007) 21
6. Marks P.A., and Breslow R. Nat. Biotechnol. 25 (2007) 84
7. Bieliauskas A.V., and Pflum M.K.H. Chem. Soc. Rev. 37 (2008) 1402
8. Karagiannis T.C., and El-Osta A. Leukemia 21 (2007) 61
9. Remiszewski S.W. Curr. Med. Chem. 10 (2003) 2393
10. Rasheed W.K., Johnstone R.W., and Prince H.M. Expert Opin. Invest. Drugs 16 (2007) 659
11. Plumb J.A., Finn P.W., Williams R.J., Bandara M.J., Romero M.R., Watkins C.J., La Thangue N.B., and Brown R. Mol. Cancer Ther. 2 (2003) 721
12. Uggy J.J., Cao Z.A., Bass K.E., Verner E., Balasubramanian S., Liu L., Schultz B.E., Young P.R., and Dalrymple S.A. Mol. Cancer Ther. 55 (2006) 1309
13. Chen, D.; Deng, W.; Lee, K. C. L.; Lye, P. L.; Sun, E. T.; Wang, H.; Yu, N. WO2007030080 A1.
14. Moradei O., Leit S., Zhou N., Fréchette S., Paquin I., Raeppel S., Gaudette F., Bouchain G., Woo S.H., Vaisburg A., Fournel M., Kalita A., Lu A., Trachy-Bourget M., Yan P., Liu J., Li Z., Rahil J., MacLeod A.R., Besterman J.M., and Delorme D. Bioorg. Med. Chem. Lett. 16 (2006) 4048
15. Mai A., Massa S., Rotili D., Simeoni S., Ragno R., Botta G., Nebbioso A., Miceli M., Altucci L., and Brosch G. J. Med. Chem. 49 (2006) 6046
16. Pisano, C.; Giannini, G.; Battistuzzi, G.; Di Marzo, M.; Pezzi, R.; Marzi, M.; Vesci, L.; Zunino, F. WO2006131482.
17. Battistuzzi G., Cacchi S., Fabrizi G., and Bernini R. Synlett (2003) 1133
18. InsEckert T., and Ipaktschi R. Synth. Commun. 28 (1998) 327
19. Barbachyn M.R., Cleek G.J., Dolak L.A., Garmon S.A., Morris J., Seest E.P., Thomas R.C., Toops D.S., Watt W., Wishka D.G., Ford C.W., Zurenko G.E., Hamel J.C., Schaadt R.D., Stapert D., Yagi B.H., Adams W.J., Friis J.M., Slatter J.G., Sams J.P., Oien N.L., Zaya M.J., Wienkers L.C., and Wynalda M.A. J. Med. Chem. 46 (2003) 284
20. Himo F., Lovell T., Hilgraf R., Rostovtsev V., Noodleman L., Sharpless K.B., and Fokin V.V. J. Am. Chem. Soc. 127 (2005) 210
21. Screening performed by Reaction Biology Corp using trichostatin A (TSA) as reference compound.